Small Cell Lung Cancer Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

JAMA Oncology : Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
Interview with Chad G. Rusthoven, MD, author of Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 4, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

Pascal Besman discusses lurbinectedin accelerated approval with FDA
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Pascal Besman, Pharmamar COO discusses advantages and potential limitations of the new d... Author: PharmaMar Added: 08/22/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Taofeek Owonikoko, MD Discusses lurbinectedin as a Potential Practice Changing in SCLC Treatment
Lurbinectedin, a potential practice changing drug if approved, will be the only agent available in SCLC tested with immunotherapy. PharmaMar to submit New Drug Application (NDA) for lurbinectedin unde... Author: PharmaMar Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2019 Category: Cancer & Oncology Source Type: podcasts

Hossein Borghaei, MD discusses lurbinectedin recent data and advantages and potential limitations of the new drug
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD discusses the recent data released and advantages and potential lim... Author: PharmaMar Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2019 Category: Cancer & Oncology Source Type: podcasts

Hossein Borghaei, MD of Fox Chase Discusses new data on lurbinectedin
PharmaMar will submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD of Fox Chase discusses the new data released and what advantages ... Author: PharmaMar Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2019 Category: Cancer & Oncology Source Type: podcasts

Recent Data on Trilaciclib in SCLC
Dr. Lowell Hart, MD, Director of Research, Florida Cancer Specialists and Research Institute explains the outcomes from the phase II study of trilaciclib in small cell lung cancer (SCLC). Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial.
Dr. Sanjay Popat, Phd, with Royal Marden Hospital, comments on Abrstract Presentation: Results from a Phase II single-agent trial. Background: Lurbinectedin (L) is a novel anticancer drug that inhi... Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Topotecan Clinical Trial: PFS Was Only A Few Months, Strong Rational To Use Topotecan As Targeted Therapy In SCLC
Rafael Santana-Davila MD @valdesan Of Fred Hutchinson Cancer Research Center Discusses Topotecan Clinical Trial: PFS Was Only A Few Months, Strong Rational To Use Topotecan As Targeted Therapy In SCLC... Author: Annual-Meeting Added: 06/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

Spanish Overview Lurbinectedin in Second-line SCLC
Dr. Luis Paz-Ares, MD, Phd of the Hospital Universitario 12 De Octubre gives a brief overview of his ASCO 2019 presentation in Spanish entitled Efficacy and safety profile of lurbinectedin in second-l... Author: Annual-Meeting Added: 06/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Overview Lurbinectedin in Second-line SCLC
Dr. Luiz Paz-Ares, MD, Phd of th Hospital Universitario 12 De Octubre gives a brief overview of his presentation from ASCO 2019 entitiled Efficacy and safety profile of lurbinectedin in second-line SC... Author: Annual-Meeting Added: 06/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Luis G. Paz-Ares, MD, Phd provides an overview of his presentation at ASCO 2019 entitled Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent... Author: PharmaMar Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 1, 2019 Category: Cancer & Oncology Source Type: podcasts

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Luis G. Paz-Ares, MD, Phd provides an overview of his presentation at ASCO 2019 entitled Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent... Author: PharmaMar Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 1, 2019 Category: Cancer & Oncology Source Type: podcasts

Radiation Management of Limited Stage SCLC
 GRACE - Global Resource for Advancing Cancer Education Published on Oct 14, 2015 Dr. Vivek Mehta, radiation oncologist, reviews the basic principles and treatment approach for limited stage smal... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts

GRACEcast 420 WCLC 2015 Practices Changed Prophylactic Cranial Irradiation Extensive Stage SCLC
 GRACE - Global Resource for Advancing Cancer Education Published on Dec 15, 2015 Drs. Ben Solomon, Leora Horn, & Jack West discuss whether the data highlighting cognitive deficits from whole bra... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts

ASCO 2018 - Keynote 158 - Keytruda in Previously Treated Now Relapsing Patients with SCLC
 GRACE - Global Resource for Advancing Cancer Education Published on Dec 5, 2018 Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of ... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts